Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details Narrative)

v3.21.2
Commitments and Contingencies (Details Narrative) - USD ($)
1 Months Ended 9 Months Ended
Aug. 28, 2019
Sep. 30, 2021
Research and development agreement   $ 550,000
Damages amount   $ 1,670,000
Represent shares of common stock 882,353 882,353
Accrued expenses   $ 100,000
Royalty payments beginning in 2022   250,000
Royalty payments beginning in 2025   2,000,000.0
Royalty payments beginning in 2027   5,000,000.0
Certain milestone payments totaling   $ 3,100,000
Minimum [Member]    
Upfront license fees   5.00%
Maximum [Member]    
Upfront license fees   6.00%